Robert Connelly - 03 Feb 2025 Form 4 Insider Report for Elicio Therapeutics, Inc. (ELTX)

Role
CEO, President and Director, Director
Signature
/s/ Robert Connelly
Issuer symbol
ELTX
Transactions as of
03 Feb 2025
Net transactions value
$0
Form type
4
Filing time
04 Feb 2025, 16:08:31 UTC
Previous filing
02 Oct 2024
Next filing
03 Feb 2026
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELTX Stock Option (Right to Buy) Award $0 +121,600 $0.000000 121,600 03 Feb 2025 Common Stock 121,600 $8.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable as to 25% of the options on the first anniversary of the grant date (February 3, 2026), with the remaining options vesting in equal monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.